2nd Quarter - Report

THE DUBERSTEIN GROUP INC. for AMGEN INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

21st Century Cures - HR 6 21st Century Cures Act. Vial size pharmaceuticals - S3040-Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017

LobbyistCovered position, as disclosed
BRIAN GRIFFIN —
DANIEL P MEYER —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th)

Medicare/Medicaid MMM

Medicare Part B pricing. Centers for Medicare and Medicaid Demonstration project regarding drug prices. Executive Action

LobbyistCovered position, as disclosed
BRIAN GRIFFIN —
DANIEL P MEYER —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Natural Resources NAT

Puerto Rico restructuring: HR5278, PROMESA; S2328, PROMESA.

LobbyistCovered position, as disclosed
KENNETH DUBERSTEIN —
BRIAN GRIFFIN —
DAVID J SCHIAPPA —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5278 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.